Maverick Capital’s Evolent Health EVH Stock Holding History

Maverick Capital’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,572,763	Closed	-$5.87M	–	224
2026 Q1	$5.87M	Buy	2,572,763 +32,833	+1%	+$104K	0.07%	55
2025 Q4	$10.2M	Buy	2,539,930 +144,646	+6%	+$804K	0.11%	54
2025 Q3	$20.3M	Buy	2,395,284 +1,002,760	+72%	+$9.73M	0.27%	53
2025 Q2	$15.7M	Buy	+1,392,524	New	+$12.8M	0.24%	50
2023 Q2	–	Sell	-11,451	Closed	-$372K	–	454
2023 Q1	$372K	Buy	+11,451	New	+$362K	0.01%	368
2021 Q4	–	Sell	-21,130	Closed	-$655K	–	428
2021 Q3	$655K	Buy	+21,130	New	+$507K	0.01%	399

Other funds holding EVH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return

Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Maverick Capital's EVH Position: Q2 2026 in Review

Maverick Capital sold out of Evolent Health (EVH) in Q2 2026, closing a stake of 2,572,763 shares — an estimated $5.87M sold.

Maverick Capital first reported a position in EVH in Q3 2021 and held it in 6 quarters. The position peaked at $20.3M in Q3 2025. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

Maverick Capital reported no remaining Evolent Health position as of Q2 2026 after selling out during the quarter.
Maverick Capital sold 2,572,763 Evolent Health shares in Q2 2026, an estimated $5.87M.
Maverick Capital first reported a position in Evolent Health in Q3 2021 and held it in 6 quarters.
Maverick Capital's Evolent Health position peaked at $20.3M in Q3 2025.
199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.